Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
First Opinion
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Live Chat
STAT+

Archive online chat: The week in biotech, JPM, and beyond

  • Adam Feuerstein
  • Rebecca Robbins
  • Matthew Herper

By Adam Feuerstein , Rebecca Robbins and Matthew Herper Jan. 11, 2019

Reprints

Couldn’t make it to this year’s J.P. Morgan Healthcare Conference? You made it but were left with questions? Join Adam Feuerstein, Rebecca Robbins, and Matt Herper for a live, subscriber-only chat about the latest in the industry and the highlights from the ground in San Francisco.

Download the chat transcript (PDF).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Matthew Herper

Matthew Herper

Senior Writer, Medicine, Editorial Director of Events

Matthew Herper covers medical innovation — both its promise and its perils.

More young people should be getting their cholesterol tested…
More young people should be getting their cholesterol tested and taking statins
How Tennessee is creating new opportunities for doctors trained…
How Tennessee is creating new opportunities for doctors trained outside the U.S.
Drug used to halt puberty in children may cause…
Drug used to halt puberty in children may cause lasting health problems
Novartis drug reduces breast cancer recurrence, but experts may…
Novartis drug reduces breast cancer recurrence, but experts may debate results
Tempus launches an AI ‘assistant’ for thousands of oncologists
Tempus launches an AI ‘assistant’ for thousands of oncologists
Pharmalittle: Appeals court rules Purdue can shield Sacklers from…
Pharmalittle: Appeals court rules Purdue can shield Sacklers from lawsuits; chemo shortage blamed on drugmakers’ lack…

Recommended Stories